This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| LabPLUS | |
|---|---|
| Name | LabPLUS |
| Established | 2004 |
| Location | Auckland, New Zealand |
| Type | Clinical and Research Laboratory |
LabPLUS is a clinical, diagnostic and biomedical research center located in Auckland. It provides pathology, molecular diagnostics, and translational research services supporting hospitals, universities, and public health agencies. The facility integrates laboratory medicine with academic programs and industry partnerships to advance precision diagnostics and public health responses.
LabPLUS operates as a large-scale laboratory complex delivering clinical services to Auckland District Health Board, supporting tertiary referral centers such as Auckland City Hospital and regional facilities including North Shore Hospital and Middlemore Hospital. It serves patient populations across the Auckland Region and coordinates with national bodies like Institute of Environmental Science and Research and Ministry of Health (New Zealand). The center provides specialized assays for infectious diseases referenced in guidelines from the World Health Organization, collaborates with academic units at University of Auckland, and contributes to surveillance programs run by Public Health England-linked initiatives and international consortia such as the Global Influenza Surveillance and Response System and the International Severe Acute Respiratory and Emerging Infection Consortium. LabPLUS personnel publish in journals affiliated with societies like the Royal Society of New Zealand and participate in conferences hosted by the Asia-Pacific Society for Clinical Microbiology and Infection and the American Society for Microbiology.
LabPLUS was established amid regional health restructuring influenced by models from institutions such as the Mayo Clinic, Johns Hopkins Hospital, and the Cleveland Clinic to centralize pathology services for efficiency and quality. Its early years coincided with public health events including the 2009 swine flu pandemic and later responses to the COVID-19 pandemic, prompting rapid expansion of molecular diagnostics, referencing protocols from the US Centers for Disease Control and Prevention and the European Centre for Disease Prevention and Control. Infrastructure developments drew on architectural and laboratory planning precedents set by facilities like the Wellcome Trust Centre for Human Genetics and capital projects informed by standards from the Health and Safety Executive (UK). Over time LabPLUS forged research links with institutions including the Liggins Institute, the Maurice Wilkins Centre, and the Auckland Bioengineering Institute.
The complex houses high-throughput platforms for nucleic acid amplification used in programs similar to those at the Karolinska Institutet and automated immunoassay analyzers comparable to systems in use at Addenbrooke's Hospital. It contains biosafety level suites modeled after designs at the Centers for Disease Control and Prevention and sample management workflows influenced by the UK Biobank. Core services include histopathology aligned with standards from the Royal College of Pathologists, clinical microbiology following criteria by the Clinical and Laboratory Standards Institute, and genomic sequencing capacity akin to the Broad Institute and the Wellcome Sanger Institute. Reference testing supports screening programs similar to those run by the Newborn Screening Programme Trust and specialized sections collaborate with pharmaceutical partners resembling GlaxoSmithKline and Roche Diagnostics for assay validation.
Research programs focus on pathogen genomics, biomarker discovery, and translational diagnostics with projects conducted alongside teams from the University of Auckland, Auckland District Health Board, and international partners such as University of Oxford, University of Melbourne, Harvard Medical School, and University of California, San Francisco. LabPLUS investigators contribute to multicenter trials registered with organizations like the International Committee of Medical Journal Editors registries and engage in precision medicine networks analogous to the All of Us Research Program and the 100,000 Genomes Project. Innovation efforts include implementing laboratory automation strategies pioneered at institutions like ETH Zurich and deploying digital pathology solutions influenced by work at Imperial College London. Outputs are disseminated through publishers such as Nature Medicine, The Lancet, and Clinical Infectious Diseases.
LabPLUS hosts clinical placements and registrar training accredited by professional bodies including the Royal Australasian College of Physicians, the Royal Australasian College of Surgeons, and the Royal College of Pathologists of Australasia. It runs postgraduate workshops with faculty from the University of Otago, professional development courses aligned with the World Association for Disaster and Emergency Medicine, and simulation-based training modeled on programs at St Thomas' Hospital. Trainees present at meetings such as the International Congress of Pathology and contribute to curricula developed in consultation with the Health Quality & Safety Commission (New Zealand).
Strategic partnerships encompass academic collaborations with the University of Auckland, translational alliances with the Maurice Wilkins Centre, and service agreements with the Auckland District Health Board. Industry collaborations include diagnostics and informatics firms comparable to Thermo Fisher Scientific, Illumina, and Siemens Healthineers. International research links exist with centers such as Oxford University Clinical Research Unit, Karolinska Institutet, and Monash University, and public health coordination occurs with agencies like the World Health Organization and the Pacific Community. LabPLUS participates in consortiums like the Global Health Security Agenda and regional networks similar to the Asia-Pacific Economic Cooperation Health Working Group.
Governance structures reflect oversight arrangements involving regional health authorities such as the Auckland District Health Board and policy guidance from the Ministry of Health (New Zealand), with advisory input from research funders including the Health Research Council of New Zealand, philanthropic bodies like the Wellcome Trust, and international grant agencies such as the National Institutes of Health (United States). Funding streams combine clinical service revenue, competitive research grants from entities like the Marsden Fund, and collaborative agreements with industry partners mirroring arrangements with companies such as Pfizer and Novo Nordisk. Accountability mechanisms include compliance with standards set by the New Zealand Accreditation Authority for Health and Disability Services and reporting aligned with frameworks used by the Organisation for Economic Co-operation and Development.
Category:Medical laboratories